Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VAC14 antisense RNA 1 (VAC14-AS1) is a long non-coding RNA produced from the antisense strand at the VAC14 locus on chromosome 16 (chr16:70755035-70773251 in GRCh38/hg38). As an antisense lncRNA, its main molecular function is likely the regulation of VAC14 gene expression through complementary base-pairing and formation of RNA duplexes, potentially modulating the translation or stability of VAC14 mRNA. There are links between this regulatory network and neurodevelopmental disorders, notably striatonigral degeneration and possibly certain cancer susceptibilities, but direct functional data and therapeutic relevance for VAC14-AS1 itself remain limited. VAC14-AS1 is not a protein-coding gene; it does not encode a receptor or enzyme and thus is not considered a conventional therapeutic target. If more structural/functional data are required, specification of the VAC14 protein itself—an important scaffold in the phosphoinositide metabolism pathway—would be relevant, but VAC14-AS1 specifically refers to the antisense lncRNA at this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VAC14 antisense RNA 1 (VAC14-AS1).